1-3 of 3
Helmut Loeffler
Close
Sort by
Journal Articles

Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

Ken I. Mills, Alexander Kohlmann, P. Mickey Williams, Lothar Wieczorek, Wei-min Liu, Rachel Li, Wen Wei, David T. Bowen, Helmut Loeffler, Jesus M. Hernandez, Wolf-Karsten Hofmann, Torsten Haferlach
Journal: Blood
Blood (2009) 114 (5): 1063–1072.
https://doi.org/10.1182/blood-2008-10-187203
Published: 2009
Includes: Supplemental data
Journal Articles

Microarray Classification of Myelodysplastic Syndrome (MDS) Identifies Subgroups with Distinct Clinical Outcomes.

Ken I. Mills, PhD, Alex Kohlmann, Ph.D., Mickey Williams, Ph.D., Wei-Min Liu, Ph.D., Rachel Li, David T. Bowen, M.D., Helmut Loeffler, M.D., Jesus M. Hernandez, M.D., Wolf-Karsten Hofmann, M.D., Torsten Haferlach, M.D., Lothar Wieczirek, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2426.
https://doi.org/10.1182/blood.V110.11.2426.2426
Published: 2007
Journal Articles

Acute Myeloid Leukemia with Translocation t(8;16) Demonstrates Specific Cytomorphological, Cytogenetic, and Gene Expression Characteristics and Can Clearly Be Discriminated from Other AML with Balanced Translocations.

Torsten Haferlach, MD, Helmut Loeffler, MD, Alexander Kohlmann, Martin Dugas, MD, Wolfgang Hiddemann, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD, Claudia Schoch, MD
Journal: Blood
Blood (2004) 104 (11): 2897.
https://doi.org/10.1182/blood.V104.11.2897.2897
Published: 2004